Creating a Healthy L.I.F.E: Lifestyle Interventions For Epilepsy

Launched by IMAD NAJM MD · Mar 7, 2022

Keywords

ClinConnect Summary

The "Creating a Healthy L.I.F.E: Lifestyle Interventions For Epilepsy" clinical trial is exploring how certain lifestyle changes, like yoga and music therapy, might help reduce the number of seizures in adults with epilepsy who are not getting enough control from their medications. This study is specifically looking for adults aged 18 to 75 who have been diagnosed with epilepsy and are experiencing at least one seizure each month. To participate, individuals must have internet access to join online sessions and should be comfortable reading at an 8th-grade level or higher.

Eligible participants will be randomly assigned to different wellness activities to see how these methods affect their seizure frequency. It's important to note that those with certain health issues or recent experience in similar therapies won't qualify for this study. If you or someone you know is interested in participating, this trial could offer a unique opportunity to explore new ways to manage epilepsy through lifestyle interventions.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Adult (ages 18-75) patients of the Cleveland Clinic Epilepsy Center with a confirmed diagnosis of epilepsy
• • Ability to independently provide informed consent
• • At the time of enrollment, patients must have had at least 1 seizure within the past 30 days
• • No anticipated anti-seizure medication adjustments
• • Internet access and the ability to participate in online video streaming
• • Reading abilities at or above 8th grade level as determined by the Wide Range Achievement Test- 4th Edition (WRAT-4) Reading subtest
• • Willing and able to participate in any of the assigned interventions which may include yoga or music therapy
• Exclusion Criteria:
• • Patients with a history of non-epileptic or psychogenic seizures
• • Any patient that has engaged in yoga or music therapy within the last 6 months
• • Currently enrolled in another interventional study for epilepsy at the time of enrollment.
• • Anticipated or scheduled epilepsy surgery within 6 months
• • Pending litigation related to the cause of epilepsy or current application for long term disability
• • Participants with a diagnosed, symptomatic, chronic illness (i.e., significant psychiatric concerns, liver, gastrointestinal, respiratory, renal, cardiac, etc.) who, based on primary investigator review, will not be able to participate in the study safely or effectively.
• • Undergoing intensive medical treatment for serious or life-threatening illness (e.g., chemotherapy, etc.) that would impact study participation.
• • Currently pregnant or less than 6 weeks postpartum
• • Significant hearing loss
• • Blindness
• • Musicogenic epilepsy or seizures